Literature DB >> 24571253

Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics.

Mary Ellen Sanders1, Todd R Klaenhammer, Arthur C Ouwehand, Bruno Pot, Eric Johansen, James T Heimbach, Maria L Marco, Julia Tennilä, R Paul Ross, Charles Franz, Nicolas Pagé, R David Pridmore, Greg Leyer, Seppo Salminen, Duane Charbonneau, Emma Call, Irene Lenoir-Wijnkoop.   

Abstract

Commercial probiotic strains for food or supplement use can be altered in different ways for a variety of purposes. Production conditions for the strain or final product may be changed to address probiotic yield, functionality, or stability. Final food products may be modified to improve flavor and other sensory properties, provide new product formats, or respond to market opportunities. Such changes can alter the expression of physiological traits owing to the live nature of probiotics. In addition, genetic approaches may be used to improve strain attributes. This review explores whether genetic or phenotypic changes, by accident or design, might affect the efficacy or safety of commercial probiotics. We highlight key issues important to determining the need to re-confirm efficacy or safety after strain improvement, process optimization, or product formulation changes. Research pinpointing the mechanisms of action for probiotic function and the development of assays to measure them are greatly needed to better understand if such changes have a substantive impact on probiotic efficacy.
© 2014 New York Academy of Sciences.

Keywords:  efficacy; gene expression; genetics; probiotic; regulatory; safety

Mesh:

Year:  2014        PMID: 24571253     DOI: 10.1111/nyas.12363

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  24 in total

1.  Attenuation of Colitis by Lactobacillus casei BL23 Is Dependent on the Dairy Delivery Matrix.

Authors:  Bokyung Lee; Xiaochen Yin; Stephen M Griffey; Maria L Marco
Journal:  Appl Environ Microbiol       Date:  2015-07-10       Impact factor: 4.792

2.  Evaluation of a Functional Craft Wheat Beer Fermented with Saccharomyces cerevisiae UFMG A-905 to treat Salmonella Typhimurium infection in mice.

Authors:  Samantha R M Oliveira; Lara L Campos; Maisa N S Amaral; Bruno Galotti; Mayra F Ricci; Katia D Vital; Ramon O Souza; Ana Paula T Uetanabaro; Mateus S Junqueira; Andreia M Silva; Simone O A Fernandes; Valbert N Cardoso; Jacques R Nicoli; Flaviano S Martins
Journal:  Probiotics Antimicrob Proteins       Date:  2022-07-30       Impact factor: 5.265

Review 3.  A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB.

Authors:  Vanessa Liévin-Le Moal
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

4.  Evaluation of genetic and phenotypic consistency of Bacillus coagulans MTCC 5856: a commercial probiotic strain.

Authors:  Muhammed Majeed; Kalyanam Nagabhushanam; Sankaran Natarajan; Arumugam Sivakumar; Talitha Eshuis-de Ruiter; Janine Booij-Veurink; Ynte P de Vries; Furqan Ali
Journal:  World J Microbiol Biotechnol       Date:  2016-02-29       Impact factor: 3.312

5.  Genotyping by PCR and High-Throughput Sequencing of Commercial Probiotic Products Reveals Composition Biases.

Authors:  Wesley Morovic; Ashley A Hibberd; Bryan Zabel; Rodolphe Barrangou; Buffy Stahl
Journal:  Front Microbiol       Date:  2016-11-03       Impact factor: 5.640

6.  Future access and improvement of industrial lactic acid bacteria cultures.

Authors:  Eric Johansen
Journal:  Microb Cell Fact       Date:  2017-12-21       Impact factor: 5.328

7.  Proteomes of Lactobacillus delbrueckii subsp. bulgaricus LBB.B5 Incubated in Milk at Optimal and Low Temperatures.

Authors:  Xiaochen Yin; Michelle R Salemi; Brett S Phinney; Velitchka Gotcheva; Angel Angelov; Maria L Marco
Journal:  mSystems       Date:  2017-09-19       Impact factor: 6.496

8.  Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing.

Authors:  Vito Trinchieri; Luca Laghi; Beatrice Vitali; Carola Parolin; Ilaria Giusti; Daniela Capobianco; Paola Mastromarino; Claudio De Simone
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

9.  Serological Biomarkers and Diversion Colitis: Changes after Stimulation with Probiotics.

Authors:  Ángela Rodríguez-Padilla; Germán Morales-Martín; Rocío Pérez-Quintero; Juan Gómez-Salgado; Carlos Ruiz-Frutos
Journal:  Biomolecules       Date:  2021-05-02

10.  Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation.

Authors:  Benedetta Cinque; Cristina La Torre; Francesca Lombardi; Paola Palumbo; Michel Van der Rest; Maria Grazia Cifone
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.